SEC Insider Transactions from Kalin Katherine Bach.

Last updated: 2026-03-14 11:44 UTC | Total transactions: 9

Director Kalin Katherine Bach purchased SELLAS Life Sciences Group ($SLS) shares on the open market twice in the last year, totaling about $137,000. Her most recent buy was on November 19, 2025. These purchases rank her 1,896th among 4,983 insiders, below the average buy of 1.5 million across 3.29 transactions. She reported no open market sales.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Jan. 7, 2026 SELLAS Life Sciences Group, Inc. $SLS Kalin Katherine Bach Director A Common Stock 50000 $0.00 154,400.0000 142,442,239 47.89% 0.04%
Nov. 19, 2025 SELLAS Life Sciences Group, Inc. $SLS Kalin Katherine Bach Director P Common Stock 63400 $1.59 104,400.0000 142,442,239 154.63% 0.04%
May 22, 2025 SELLAS Life Sciences Group, Inc. $SLS Kalin Katherine Bach Director P Common Stock 20000 $1.80 41,000.0000 90,846,692 95.24% 0.02%
Jan. 10, 2025 SELLAS Life Sciences Group, Inc. $SLS Kalin Katherine Bach Director A Stock Option (Right to Buy) 18500 $0.00 18,500.0000 0 9999.99% 0.00%
Jan. 10, 2025 SELLAS Life Sciences Group, Inc. $SLS Kalin Katherine Bach Director A Common Stock 12500 $0.00 21,000.0000 0 147.06% 0.00%
Jan. 22, 2024 SELLAS Life Sciences Group, Inc. $SLS Kalin Katherine Bach Director A Common Stock 6000 $0.00 8,500.0000 0 240.00% 0.00%
Jan. 22, 2024 SELLAS Life Sciences Group, Inc. $SLS Kalin Katherine Bach Director A Stock Option (Right to Buy) 10000 $0.00 10,000.0000 0 9999.99% 0.00%
Feb. 2, 2023 SELLAS Life Sciences Group, Inc. $SLS Kalin Katherine Bach Director A Common Stock 2500 $0.00 2,500.0000 0 9999.99% 0.00%
Feb. 2, 2023 SELLAS Life Sciences Group, Inc. $SLS Kalin Katherine Bach Director A Stock Option (Right to Buy) 9500 $0.00 9,500.0000 0 9999.99% 0.00%